Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
10/2005
10/19/2005CN1683354A 4-hydroxy pyrone compounds with anti-HIV activity, preparing method and use
10/18/2005CA2294171C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
10/13/2005WO2005095376A1 Antiviral agents
10/13/2005WO2005095375A1 Extract of sophora flavescens flavonoids and uses thereof
10/13/2005WO2005095343A1 Dpp-iv inhibitors
10/13/2005WO2005095326A2 2-amino- and 2-thio-substituted 1,3-diaminopropanes
10/13/2005WO2005070910A3 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
10/13/2005WO2005058798A8 Compounds having selective cytochrome p450rai-1 or selective cytochrome p450rai-2 inhibitory activity and methods of obtaining the same
10/13/2005WO2005033288A3 Hedgehog pathway antagonists
10/13/2005WO2004099105A3 Pesticidal (dihalopropenyl) phenylalkyl substituted benzoxazole and benzothiazole derivatives
10/13/2005US20050228040 Bicyclic aromatic sulfinyl derivatives
10/13/2005US20050227987 11beta-hydroxysteroid dehydrogenase inhibitors
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227973 Human adam-10 inhibitors
10/13/2005US20050227967 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
10/13/2005US20050226828 Method for whitening human skin
10/13/2005CA2561896A1 Antiviral agents
10/13/2005CA2560773A1 2-amino- and 2-thio-substituted 1,3-diaminopropanes
10/13/2005CA2558446A1 Dpp-iv inhibitors
10/12/2005EP1584621A1 A process for the preparation of tolterodine and intermediates thereof
10/12/2005EP1584485A2 Lithographic printing plate precursor and lithographic printing method
10/12/2005EP1583753A1 Process for the manufacture of alpha-tocopheryl acetate
10/12/2005EP1583726A2 Activity-based probes, and methods of their preparation and use
10/12/2005EP1583458A2 Lipophilic electrophoretic probes
10/12/2005EP1383763B1 Method for producing 2-(-5-(4-fluorophenyl)-3-pyridylmethylaminomethyl)-chromane
10/12/2005EP1355898B1 Method for producing flavone derivatives
10/12/2005EP0954522B1 Novel substituted naphthopyrans
10/12/2005CN1681792A 9-cyano-substituted perylene-3, 4-dicarboxylic acid monoimides
10/12/2005CN1681386A Compositions and products containing s-equol, and methods for their making
10/12/2005CN1680402A Water soluble prodrugs of hindered alcohols
10/12/2005CN1680391A Preparation of bromo-dihydroartemisine
10/12/2005CN1680390A Halogenated dihydroartemisine, preparation and use thereof
10/12/2005CN1680389A Bromo-dihydroartemisine
10/12/2005CN1680388A Extraction of artemisine
10/12/2005CN1680386A Production of high-purity glabrene
10/12/2005CN1680385A Separation and extraction of icariin A
10/12/2005CN1680383A Indicated tetraodotoxin, preparation and use thereof
10/12/2005CN1680382A Preparation of tetraodotoxin by two-step resin method and tetraodotoxin preparation thereof
10/12/2005CN1680381A Preparation of S-tricyctic lactone
10/12/2005CN1680359A Purification of oligo-proanthocyanidin from grape seed by membrane ultrafilter method
10/12/2005CN1680358A Composition concerned with isoflavone and the similar and therapeutical method
10/12/2005CN1680357A Extraction of soya isoflavone, concentrated soya protein and soya oligose
10/12/2005CN1680356A Extraction of flavone and polysaccharose from edible flowers
10/12/2005CN1680355A Preparation of suaveolic flavone for treating chronic pharyngitis and chronic tonsilltiis
10/12/2005CN1680354A Use of cyclodextrin in extraction of ginkgetin
10/12/2005CN1680353A Rice bean flavone extracts and their use
10/12/2005CN1680240A Composition containing resveratrol and soybean isoflavone and its preparation and use
10/12/2005CN1680220A Agent of extracting polyphenol from rape seed cakes or husks and its preparation
10/12/2005CN1679556A Valdecoxib compositions
10/12/2005CN1222518C Fluorescent probes for quantitation of zinc
10/11/2005US6953801 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
10/06/2005WO2005092879A1 Novel process
10/06/2005WO2005092878A2 Schweinfurthin analogues
10/06/2005WO2005092876A1 Synthesis of rocaglamide natural products via photochemical generation of oxidopyrylium species
10/06/2005WO2005092825A1 Process for production of optically active alcohols
10/06/2005WO2005092338A1 Process for the preparation of 3-amino-8-(1-piperazinyl) -2h-1-benzopyran-2-one and salts and hydrates thereof
10/06/2005WO2005092327A1 Periodontal ligament-protecting agent
10/06/2005WO2005092326A1 Small molecule antagonists of xiap family proteins
10/06/2005WO2005092316A1 Novel pharmaceutical compositions comprising agonists of the thyroid receptor
10/06/2005WO2005049562A3 Novel cyclic oxygenated compounds having cooling, fragrance, and flavor properties, and uses thereof
10/06/2005US20050222437 Process for the preparation of tolterodine and intermediates thereof
10/06/2005US20050222423 Carboxylic acid derivative
10/06/2005US20050222255 Process for producing trans-4-amino-1-cyclohexanecarboxilic acid derivative
10/06/2005US20050222248 3'-hydroxy-dihydrodaidzein, 5-hydroxy-O-demethylangolesin; for treating hormone dependent conditions and other diseases and disorders; anticarcinogenic agents; menopausal syndrome; osteoporosis; rheumatic diseases; atherosclerosis; premenstrual syndrome; coronary artery spasm; vascular diseases
10/06/2005US20050222247 Chroman derivatives
10/06/2005US20050222195 administering bi-cyclic and mono-cyclic tautomers of 13,14-dihydro-15-keto-16,16-difluoro-prostaglandin E1 in triglyceride, for treating constipation without substantive side-effects, such as stomach ache
10/06/2005US20050220753 Hydrophilic polymers-flavoids conjugates and pharmaceutical compositions comprising them
10/06/2005CA2561160A1 Novel process
10/06/2005CA2560557A1 Schweinfurthin analogues
10/06/2005CA2560526A1 Novel pharmaceutical compositions comprising agonists of the thyroid receptor
10/06/2005CA2554041A1 Process for the preparation of 3-amino-8-(1-piperazinyl) -2h-1-benzopyran-2-one and salts and hydrates thereof
10/06/2005CA2520166A1 A protectant of periodontal membranes
10/05/2005EP1581512A2 Analogs of green tea polyphenols as chemotherapeutic and chemopreventive agents
10/05/2005EP1581476A2 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
10/05/2005EP1581209A2 Novel benzopyran analogs and their use for the treatment of glaucoma
10/05/2005EP1401823B1 Substituted benzopyran derivatives against arrhythmia
10/05/2005CN1678603A Process for producing aminobenzopyran compound
10/05/2005CN1678303A Keto cannabinoids with therapeutic indications
10/05/2005CN1678302A Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
10/05/2005CN1676521A Kuh-seng ketone and its derivative and the like and use in preparing anti-tumor medicine
10/05/2005CN1676520A Kuh-seng flavone extract and preparation and use thereof
10/05/2005CN1221543C Preparation method of d-alpha tocopherol
10/05/2005CN1221542C Methods for separating tocol from tocol-containing mixture
10/05/2005CN1221514C Intermediate for preparing alkyl-dihalogeno phenyl substituted keto-enol
10/04/2005US6951943 Integrin inhibitors
10/04/2005US6951883 2H-1-benzopyran derivatives processes for their preparation and pharmaceutical compositions thereof
10/04/2005US6951877 Materials and methods for treating hypercholesterolemia
10/04/2005US6951870 Ortho-diihydroxy- coumarin or 1,2--dihydroquinoline derivatives as catechol-O-methyltransferase enzyme inhibitors for Parkinson*s disease treatment
09/2005
09/30/2005CA2502640A1 A process for the preparation of tolterodine and intermediates thereof
09/29/2005WO2005090336A1 2-propanol and 2-propylamine derivatives and their use as glucocorticoid ligands
09/29/2005WO2005042697A3 Compounds, compositions and methods
09/29/2005US20050215627 Application of substances acting as cascade inhibitors of the Raf/MEK/ERK signaling cascade for the production of a drug against DNA and RNA viruses
09/29/2005US20050215594 Diabetes, obesity, urogenital disorders, cardiovascular disorders, atherosclerosis; 4-[(2R)-2-(([(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino)methyl)-3,4-dihydro-2H-chromen-6-yl]benzoic acid for example
09/29/2005US20050215566 Process for the preparation of 3-amino-8-(1-piperazinyl)-2H-1-benzopyran-2-one and salts and solvates thereof
09/29/2005US20050215493 Calcium-containing tissue strengthening agents and use thereof
09/29/2005DE102004011265A1 Preparation of chroman compounds, useful to prepare vitamin E compounds, which are useful as antioxidants, comprises reaction of phenol compounds with alkene compounds, catalysts (with chiral or achiral ligand) and oxidizing agents
09/29/2005CA2559310A1 7h-8,9-dihydro-pyrano (2,3-c) imidazo (1,2a) pyridine derivatives and their use as gastric acid secretion inhibitors
09/29/2005CA2558023A1 2-propanol and 2-propylamine derivatives and their use as glucocorticoid ligands
09/28/2005EP1243583B1 Heterocyclic compounds having sulfonamide groups
09/28/2005CN1674937A Remedy or preventive for kidney disease and method of diagnosing kidney disease
1 ... 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 ... 242